User:Reverkd'19/sandbox

Early life and education
Holmes was born in February 1984 in Washington, D.C. She is the daughter of government service worker Christian Holmes IV and congressional committee staffer Noel Dauost. When she was 9 years old, Holmes and her younger brother Christian Holmes V moved to Houston, Texas due to her family's job relocation. She wrote a letter to her father about the move saying, "What I really want out of life is to discover something new, something that mankind didn't know was possible to do." Holmes studied Mandarin as a child and completed three years of summer language classes at Stanford University before graduating high school.

She attended St. John's School in Houston and was recognized for her "tireless optimism and a particularly warm smile." During high school, Holmes was interested in computer programming and started her first business selling C++ compilers to Chinese universities. After the end of her freshman year at Stanford University, Holmes worked in a lab at the Genome Institute of Singapore on testing for severe acute respiratory syndrome (SARS) through the collection of blood samples with syringes. She filed her first patent on a wearable drug-delivery patch in 2003. In March 2004, she left Stanford's School of Engineering and used her tuition money as seed funding for a consumer healthcare technology company.

Career
Holmes originally founded the company in Palo Alto, California as Real-Time Cures to "democratize healthcare." She changed the company's name to Theranos (an amalgam of "therapy" and "diagnosis").

Theranos claimed to have developed a blood-testing device named "Edison" that uses a few drops of blood obtained via a finger-stick rather than vials of blood obtained via traditional venipuncture, using microfluidics technology.

By December 2004, she had raised $6 million to fund Theranos. The company's first revenue came from contracts Holmes established with pharmaceutical companies to conduct testing and other clinical trials. By the end of 2010, Holmes had more than $92 million in venture capital for Theranos. In July 2011, Holmes was introduced to former Secretary of State George Shultz. After a two hour meeting, he joined the Theranos board of directors. She was recognized for forming "the most illustrious board in U.S. corporate history" over the next three years. Holmes operated Theranos in stealth mode without press releases or a company website until September 2013 when the company announced a partnership with Walgreens to make in-store blood sample collection centers.

Media attention increased in 2014 as she was on the cover of Fortune, Forbes, T: The New York Times Style Magazine and Inc., who considered her "The Next Steve Jobs". Forbes recognized Holmes as the world's youngest self-made female billionaire and ranked her #110 on the Forbes 400 in 2014. Theranos was valued at $9 billion with more than $400 million in venture capital. By the end of 2014, she had 18 U.S. patents and 66 non-U.S. patents in her name.

The Wall Street Journal stated that the Edison blood-testing device by Theranos might provide inaccurate results in October 2015. Holmes denied the claims and said the company would publish data on the accuracy of its tests.

In January 2016, the Centers for Medicare and Medicaid Services sent a warning letter to Theranos after inspecting its Newark, California laboratory. CMS regulators proposed a two year ban on Holmes from owning or operating a blood lab after the company had not fixed problems within its California lab in March 2016. On The Today Show, Holmes said that she was "devastated we did not catch and fix these issues faster" and that the lab would be rebuilt with help from a new scientific and medical advisory board.

In July 2016, the CMS banned Holmes from owning, operating or directing a blood testing service for a period of two years; revoked regulatory approvals for the Newark, California lab; barred the lab from receiving Medicare and Medicaid payments; and imposed an unspecified monetary penalty. Experts in the field stated that such a step was unprecedented for a clinical-laboratory company of such size and prominence. The sanctions were to take effect 60 days from the date of issuance; Theranos and Holmes could appeal the CMS's decision to an administrative law judge and then a U.S. Department of Health and Human Services appeals board, and while the appeal was pending the sanctions would not take effect. The company further stated on July 8 that “The clinical lab is just one of Theranos’ many opportunities to provide access to high-integrity, affordable and actionable health care information, and the company will continue to carry out its mission under the leadership of its founder and CEO, Elizabeth Holmes”.

Awards and recognition
Fortune magazine named Holmes one of the "Most Disappointing leaders" in 2016, after the lab controversy. She had previously been named one of TIME's Most Influential People in the World in 2015. Holmes received the "Under 30 Doers" Award from Forbes and ranked on its 2015 list of the "Most Powerful Women". As recently as 2014, Holmes was ranked in Fortune's "Businessperson of the Year" and "40 Under 40" lists.

She was also named "Woman of the Year" by Glamour. Holmes was awarded the 2015 Horatio Alger Award, being the youngest recipient in its history.

In 2016, she was the focus of a Forbes re-evaluation of her net worth, producing a new estimate of "nothing".

Personal life
Her father, Christian Rasmus Holmes IV, worked in the United States, Africa, and China as part of government agencies such as USAID. Her mother, Noel Anne Dauost, worked as a Congressional committee staffer. Holmes describes her fear of needles as one of her motivations for founding Theranos. She is known for wearing black turtlenecks, which was inspired by Sharon Stone's attire at the 1996 Academy Awards.

Holmes has 50 percent ownership of stock in Theranos. Forbes listed her as one of "America's Richest Self-Made Women" in 2015 with a net worth of $4.5 billion. In June 2016, Forbes released an updated value of Theranos, which estimated its worth as $800 million with Holmes having a net worth of zero in the company.

She is a descendent of Charles Louis Fleischmann, the founder of the Fleischmann's Yeast company. Holmes is also a descendent of Christian R. Holmes, a surgeon, engineer, inventor, and a decorated World War I veteran.